N-(3-cyano-4,5-dimethylthiophen-2-yl)acetamide, 98%, 1g

Ethyl 4-chlorothieno[3,2-d]pyrimidine-6-carboxylate, 95.0%, 5g

1-(Triisopropylsilyl)indole>94.0%(GC)1g

trans-4-[Bis(phenylmethyl)amino]cyclohexanecarboxylic acid, 97%, 250mg

Ethyl 3-(2,6-dichlorophenyl)-3-oxopropanoate, 95.0%, 1g

(2-(Benzyloxy)-4,5-difluorophenyl)methanol, 95%, 1g

N-(1-naftil)-etilendiamina, diclorhidrato mínimo 99 %, pa, 10 g, envase de vidrio

8-Chloro-1,2,3,4-tetrahydroquinoline hydrochloride, 95+%, 250mg

Puntas de pipeta 1-50 μl, Estándar, Unidad de recambio (paletizada), No estéril, 960 Piezas

1,2-Bis[(2R,5R)-2,5-dimethylphospholano]benzene>98.0%(GC)100mg

Methyl 3-(trifluoromethyl)benzoate, 98.0%, 25g

(R)-2-(Hydroxymethyl)-4,4-difluoropyrrolidine HCl, 95.0%, 500mg

N2-(1H-1,3-benzodiazol-6-yl)-N4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine, 98%, 25mg